A novel mutation in SOX3 polyalanine tract : a case of Kabuki syndrome with combined pituitary hormone deficiency harboring double mutations in MLL2 and SOX3
INTRODUCTION: Both duplications encompassing SOX3 and loss-of function mutations in SOX3 have been reported in a minor portion of X-linked isolated growth hormone deficiency (GHD) or combined pituitary hormone deficiency (CPHD) patients with or without mental retardation.
PATIENTS AND METHODS: We report a Japanese male patient with molecularly confirmed Kabuki syndrome who was found to have CPHD. We analyzed all coding exons and flanking introns of currently known nine genes responsible for CPHD by PCR-based sequencing.
RESULTS: In this CPHD patient, we identified a novel hemizygous 21-base pair deletion, resulting in the loss of 7 alanine residues from polyalanine (PA) tracts of SOX3. The clinically and endocrinologically normal mother of the patient carried the same deletion in a heterozygous manner. In vitro experiments showed that the del 7A SOX3 had increased transactivation of the HESX1 promoter.
CONCLUSION: Our study provides additional evidence that deletion in PA tracts of SOX3 is associated with hypopituitarism. Female carriers of SOX3 PA tract deletions will show a broad phenotypic spectrum, ranging from clinically normal to CPHD.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2014 |
---|---|
Erschienen: |
2014 |
Enthalten in: |
Zur Gesamtaufnahme - volume:17 |
---|---|
Enthalten in: |
Pituitary - 17(2014), 6 vom: 01. Dez., Seite 569-74 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Takagi, Masaki [VerfasserIn] |
---|
Links: |
---|
Themen: |
Case Reports |
---|
Anmerkungen: |
Date Completed 01.07.2015 Date Revised 21.10.2021 published: Print Citation Status MEDLINE |
---|
doi: |
10.1007/s11102-013-0546-5 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM233743626 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM233743626 | ||
003 | DE-627 | ||
005 | 20231224095751.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231224s2014 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1007/s11102-013-0546-5 |2 doi | |
028 | 5 | 2 | |a pubmed24n0779.xml |
035 | |a (DE-627)NLM233743626 | ||
035 | |a (NLM)24346842 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Takagi, Masaki |e verfasserin |4 aut | |
245 | 1 | 2 | |a A novel mutation in SOX3 polyalanine tract |b a case of Kabuki syndrome with combined pituitary hormone deficiency harboring double mutations in MLL2 and SOX3 |
264 | 1 | |c 2014 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 01.07.2015 | ||
500 | |a Date Revised 21.10.2021 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a INTRODUCTION: Both duplications encompassing SOX3 and loss-of function mutations in SOX3 have been reported in a minor portion of X-linked isolated growth hormone deficiency (GHD) or combined pituitary hormone deficiency (CPHD) patients with or without mental retardation | ||
520 | |a PATIENTS AND METHODS: We report a Japanese male patient with molecularly confirmed Kabuki syndrome who was found to have CPHD. We analyzed all coding exons and flanking introns of currently known nine genes responsible for CPHD by PCR-based sequencing | ||
520 | |a RESULTS: In this CPHD patient, we identified a novel hemizygous 21-base pair deletion, resulting in the loss of 7 alanine residues from polyalanine (PA) tracts of SOX3. The clinically and endocrinologically normal mother of the patient carried the same deletion in a heterozygous manner. In vitro experiments showed that the del 7A SOX3 had increased transactivation of the HESX1 promoter | ||
520 | |a CONCLUSION: Our study provides additional evidence that deletion in PA tracts of SOX3 is associated with hypopituitarism. Female carriers of SOX3 PA tract deletions will show a broad phenotypic spectrum, ranging from clinically normal to CPHD | ||
650 | 4 | |a Case Reports | |
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 7 | |a DNA-Binding Proteins |2 NLM | |
650 | 7 | |a KMT2D protein, human |2 NLM | |
650 | 7 | |a Neoplasm Proteins |2 NLM | |
650 | 7 | |a SOX3 protein, human |2 NLM | |
650 | 7 | |a SOXB1 Transcription Factors |2 NLM | |
700 | 1 | |a Ishii, Tomohiro |e verfasserin |4 aut | |
700 | 1 | |a Torii, Chiharu |e verfasserin |4 aut | |
700 | 1 | |a Kosaki, Kenjiro |e verfasserin |4 aut | |
700 | 1 | |a Hasegawa, Tomonobu |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Pituitary |d 1998 |g 17(2014), 6 vom: 01. Dez., Seite 569-74 |w (DE-627)NLM097524530 |x 1573-7403 |7 nnns |
773 | 1 | 8 | |g volume:17 |g year:2014 |g number:6 |g day:01 |g month:12 |g pages:569-74 |
856 | 4 | 0 | |u http://dx.doi.org/10.1007/s11102-013-0546-5 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 17 |j 2014 |e 6 |b 01 |c 12 |h 569-74 |